Author Question: Which of the following best describes why clients with dual diagnoses are difficult to diagnose? ... (Read 60 times)

crobinson2013

  • Hero Member
  • *****
  • Posts: 535
Which of the following best describes why clients with dual diagnoses are difficult to diagnose?
 
  A) Nonhomogeneous, poor historians, and noncompliant
  B) Homogeneous group with good supports, but lack of finances
  C) Low social supports and self-esteem
  D) Lack of financial resources and social supports and poor historians

Question 2

Evaluation of the dually diagnosed client's progress is often a difficult process. Which of the following best describes the problem with this ongoing, ever-changing process?
 
  A) Clients often run out of money for treatment during this phase.
  B) Clients' families become burned out during this phase.
  C) Clients have a high potential for relapse and recidivism during this phase.
  D) Clients do not often continue to participate in treatment after detoxification.



shaquita

  • Sr. Member
  • ****
  • Posts: 324
Answer to Question 1

Ans: A
Clients with a dual diagnosis are difficult to assess because they are not a homogenous group. In addition, clients often are poor historians and noncompliant during the assessment process. They may present for assessment on a voluntary basis because they desire help, they may be adjudicated by the court system to be evaluated prior to sentencing for a crime, or they may be referred by another health care professional to rule out the presence of a comorbid psychiatric disorder.

Answer to Question 2

Ans: C
Evaluation of the client's progress is an ongoing process that can be challenging due to the potential for relapse or recidivism. Evaluation focuses on compliance by the client, the stated outcomes, the effectiveness of interventions, and the client's progress.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
 

Did you know?

The newest statin drug, rosuvastatin, has been called a superstatin because it appears to reduce LDL cholesterol to a greater degree than the other approved statin drugs.

Did you know?

Disorders that may affect pharmacodynamics include genetic mutations, malnutrition, thyrotoxicosis, myasthenia gravis, Parkinson's disease, and certain forms of insulin-resistant diabetes mellitus.

Did you know?

Everyone has one nostril that is larger than the other.

Did you know?

Calcitonin is a naturally occurring hormone. In women who are at least 5 years beyond menopause, it slows bone loss and increases spinal bone density.

Did you know?

Interferon was scarce and expensive until 1980, when the interferon gene was inserted into bacteria using recombinant DNA technology, allowing for mass cultivation and purification from bacterial cultures.

For a complete list of videos, visit our video library